106 related articles for article (PubMed ID: 12208317)
1. SCH 58261 differentially influences quinolinic acid-induced effects in striatal and in hippocampal slices.
Tebano MT; Domenici MR; Popoli P
Eur J Pharmacol; 2002 Aug; 450(3):253-7. PubMed ID: 12208317
[TBL] [Abstract][Full Text] [Related]
2. Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum.
Popoli P; Pintor A; Domenici MR; Frank C; Tebano MT; Pèzzola A; Scarchilli L; Quarta D; Reggio R; Malchiodi-Albedi F; Falchi M; Massotti M
J Neurosci; 2002 Mar; 22(5):1967-75. PubMed ID: 11880527
[TBL] [Abstract][Full Text] [Related]
3. Adenosine A2A receptor blockade differentially influences excitotoxic mechanisms at pre- and postsynaptic sites in the rat striatum.
Tebano MT; Pintor A; Frank C; Domenici MR; Martire A; Pepponi R; Potenza RL; Grieco R; Popoli P
J Neurosci Res; 2004 Jul; 77(1):100-7. PubMed ID: 15197743
[TBL] [Abstract][Full Text] [Related]
4. Adenosine A(2A) antagonism increases striatal glutamate outflow in the quinolinic acid rat model of Huntington's disease.
Gianfriddo M; Corsi C; Melani A; Pèzzola A; Reggio R; Popoli P; Pedata F
Brain Res; 2003 Jul; 979(1-2):225-9. PubMed ID: 12850590
[TBL] [Abstract][Full Text] [Related]
5. Adenosine A2A receptor antagonism increases striatal glutamate outflow in dopamine-denervated rats.
Corsi C; Pinna A; Gianfriddo M; Melani A; Morelli M; Pedata F
Eur J Pharmacol; 2003 Mar; 464(1):33-8. PubMed ID: 12600692
[TBL] [Abstract][Full Text] [Related]
6. SCH 58261 (an adenosine A(2A) receptor antagonist) reduces, only at low doses, K(+)-evoked glutamate release in the striatum.
Pintor A; Quarta D; Pèzzola A; Reggio R; Popoli P
Eur J Pharmacol; 2001 Jun; 421(3):177-80. PubMed ID: 11516434
[TBL] [Abstract][Full Text] [Related]
7. Transducing system operated by adenosine A(2A) receptors to facilitate acetylcholine release in the rat hippocampus.
Rebola N; Oliveira CR; Cunha RA
Eur J Pharmacol; 2002 Nov; 454(1):31-8. PubMed ID: 12409002
[TBL] [Abstract][Full Text] [Related]
8. Effect of A2A adenosine receptor stimulation and antagonism on synaptic depression induced by in vitro ischaemia in rat hippocampal slices.
Latini S; Bordoni F; Corradetti R; Pepeu G; Pedata F
Br J Pharmacol; 1999 Nov; 128(5):1035-44. PubMed ID: 10556941
[TBL] [Abstract][Full Text] [Related]
9. The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist.
Zocchi C; Ongini E; Conti A; Monopoli A; Negretti A; Baraldi PG; Dionisotti S
J Pharmacol Exp Ther; 1996 Feb; 276(2):398-404. PubMed ID: 8632302
[TBL] [Abstract][Full Text] [Related]
10. Different synaptic and subsynaptic localization of adenosine A2A receptors in the hippocampus and striatum of the rat.
Rebola N; Canas PM; Oliveira CR; Cunha RA
Neuroscience; 2005; 132(4):893-903. PubMed ID: 15857695
[TBL] [Abstract][Full Text] [Related]
11. The selective A2A receptor antagonist SCH 58261 reduces striatal transmitter outflow, turning behavior and ischemic brain damage induced by permanent focal ischemia in the rat.
Melani A; Pantoni L; Bordoni F; Gianfriddo M; Bianchi L; Vannucchi MG; Bertorelli R; Monopoli A; Pedata F
Brain Res; 2003 Jan; 959(2):243-50. PubMed ID: 12493612
[TBL] [Abstract][Full Text] [Related]
12. Cross talk between A(1) and A(2A) adenosine receptors in the hippocampus and cortex of young adult and old rats.
Lopes LV; Cunha RA; Ribeiro JA
J Neurophysiol; 1999 Dec; 82(6):3196-203. PubMed ID: 10601453
[TBL] [Abstract][Full Text] [Related]
13. Modulation of glutamate release and excitotoxicity by adenosine A2A receptors.
Popoli P; Frank C; Tebano MT; Potenza RL; Pintor A; Domenici MR; Nazzicone V; Pèzzola A; Reggio R
Neurology; 2003 Dec; 61(11 Suppl 6):S69-71. PubMed ID: 14663014
[TBL] [Abstract][Full Text] [Related]
14. Effects of the adenosine A2A receptor antagonist SCH 58621 on cyclooxygenase-2 expression, glial activation, and brain-derived neurotrophic factor availability in a rat model of striatal neurodegeneration.
Minghetti L; Greco A; Potenza RL; Pezzola A; Blum D; Bantubungi K; Popoli P
J Neuropathol Exp Neurol; 2007 May; 66(5):363-71. PubMed ID: 17483693
[TBL] [Abstract][Full Text] [Related]
15. Striatal A2A adenosine receptor antagonism differentially modifies striatal glutamate outflow in vivo in young and aged rats.
Corsi C; Melani A; Bianchi L; Pedata F
Neuroreport; 2000 Aug; 11(11):2591-5. PubMed ID: 10943728
[TBL] [Abstract][Full Text] [Related]
16. Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.
Dionisotti S; Ongini E; Zocchi C; Kull B; Arslan G; Fredholm BB
Br J Pharmacol; 1997 Jun; 121(3):353-60. PubMed ID: 9179373
[TBL] [Abstract][Full Text] [Related]
17. Adenosine and dopamine receptor antagonist binding in the rat ventral and dorsal striatum: lack of changes after a neonatal bilateral lesion of the ventral hippocampus.
Lillrank SM; Lipska BK; Weinberger DR; Fredholm BB; Fuxe K; Ferré S
Neurochem Int; 1999 Mar; 34(3):235-44. PubMed ID: 10355490
[TBL] [Abstract][Full Text] [Related]
18. Characterization of A2A adenosine receptors in human lymphocyte membranes by [3H]-SCH 58261 binding.
Varani K; Gessi S; Dalpiaz A; Ongini E; Borea PA
Br J Pharmacol; 1997 Sep; 122(2):386-92. PubMed ID: 9313951
[TBL] [Abstract][Full Text] [Related]
19. Enhanced adenosine A2A receptor facilitation of synaptic transmission in the hippocampus of aged rats.
Rebola N; Sebastião AM; de Mendonca A; Oliveira CR; Ribeiro JA; Cunha RA
J Neurophysiol; 2003 Aug; 90(2):1295-303. PubMed ID: 12904509
[TBL] [Abstract][Full Text] [Related]
20. SCH 58261, a selective adenosine A2A receptor antagonist, decreases the haloperidol-enhanced proenkephalin mRNA expression in the rat striatum.
Wardas J; Pietraszek M; Dziedzicka-Wasylewska M
Brain Res; 2003 Jul; 977(2):270-7. PubMed ID: 12834887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
